ENTOURAGE HEALTH CORP (ENTG.CA)
CA2938611001 - Common Stock
Entourage Health Reports Second Quarter 2024 Financial Results
Total revenue of $12.2 million demonstrates the Company's solid momentum year over year and ongoing growth in the rapidly expanding bulk sales...
Entourage Health to Host Second Quarter 2024 Financial Results Call
TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (
Entourage Announces Results of 2024 Annual General Meeting of Shareholders
TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian...
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
Entourage's solid financial performance entering 2024 underscores its positive trajectory and positions the Company for continued success in upcoming...
Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®
Entourage Unveils Exciting New Product Offerings Diversifying the Company’s Signature BrandsDime Bag® Widens Reach: Popular Offerings Now Across Alberta ...
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
Strategic Cost Management Signals Stronger Financial Health and Future Stability...
Entourage Health to Report Fiscal Year 2023 Financial Results
Company Financials for Full-Year 2023 will be filed after market close on April 29, 2024...
Entourage Health Provides Corporate Update
Chief Legal Officer and Corporate Secretary to step down effective December 18, 2023 TORONTO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Entourage Health...
Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue
Entourage sees the benefits of transitioning from cultivation and reports over $10 million to date in annualized cost savings.Gross Profit Before Fair...
Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian...
Entourage Health Announces Amendment to Key Supply Agreement
Supply Agreement previously executed with HEXO Corp. is assigned to Aphria Inc., Tilray Brands, Inc.’s operating subsidiary for bulk cannabis biomass ...
Entourage Health Reports Second Quarter 2023 Financial Results
The Company achieved a total revenue of $13.3 million, driven by an 8% increase in adult-use revenue and a significant 45% increase in pre-roll revenue...
Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis
Entourage addresses market demand for affordable premium cannabis with new brand, Dime Bag® The Company announces Syndicate, a collective of exclusive...
Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30
Financial filings are expected after market August 29, with a management conference call to follow the next day...
Entourage Health Announces International Sale of Bulk Cannabis to Australia
Company successfully executes international sale and fulfilment of 100kg order of Bulk Medical Cannabis with Lyphe AustraliaCompany also issues Deferred...
Entourage Health Announces Restructuring of Senior Secured Debt
Senior secured credit facility is repaid in part from proceeds of facility sale and the balance assumed by LPFSale of Strathroy facility concludes site...
Entourage Health Announces Results of 2023 Annual General Meeting of Shareholders
TORONTO, June 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian...
Entourage Health Reports First Quarter 2023 Financial Results
Total revenue of $15.1 million in Q1 2023 represents a 24% sequential increase over Q4 2022.Net Revenue in medical accounted for $6.0 million, a 61%...
Entourage Health to Host First Quarter 2023 Earnings Conference Call
Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company...
Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues
The Company positions its 2023 business outlook to drive profitability and deliver enhanced premium product offerings, paving the way for long-term...
Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results
Company Financials for Full-Year 2022 to be filed by May 1, 2023....
Entourage Health Announces Timing of Fiscal Year End 2022 Conference Call for April 28
Company financials to be filed after market on April 27, 2023, and operational outlook to be provided during call, including milestones achieved...
Entourage Health Corp Issues Deferred Share Units and Enters into Shares-for-Debt Agreements
TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian...
Entourage Health and LiUNA Pension Fund Close on $15M of Previously Announced Debt Financing
Company also confirms it has signed an amended and restated credit agreement with LiUNA...
Entourage Health's Color Cannabis Receives 2022 ADCANN Award for Canadian Marketing Campaign of the Year
Consumer-facing cannabis awards recognize the brands' 'Just Add Color' marketing campaign as the best in 2022Company’s Chief People Officer resigning...
Entourage Health Updates Senior Secured Amended and Restated Credit Facility
TORONTO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian...
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
Company signs three-year supply agreement with HEXO Corp. to buy bulk cannabis for its expanding retail distribution and increased medical...
HEXO and Entourage Health Sign Long-Term Supply Agreement
HEXO to provide bulk supply to Entourage over three-year period for multi-channel distribution
Entourage Health to Host Third Quarter 2022 Financial Results Call on November 15
TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $30 Million in Non-Dilutive Funding Availability
Company also confirms it has signed an updated amended and restated credit agreement with senior lender, Bank of Montreal...
Entourage Launches New Suite of 15 Innovative Color Cannabis and Saturday Cannabis Products for its Largest Retail Product Call to Date
Debuts: ‘Color Calendar’, a unique take on an adult-use Advent calendar featuring 24 pre-rolls; ‘Saturday Cranberry Sauce’ vape; ‘Color Live Resin Soft...
Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers
Syndicate marketplace showcases a variety of specially curated products and formats made in-house and/or sourced from micro-cultivators looking for a...
Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer
New role optimizes resources in cultivation, production and supply chain for maximum output...
Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program
Plan administrator Union Benefits adds four union groups and six new southwestern Ontario locals, providing access to medical cannabis as an insured...